Lotus Pharmaceuticals, Inc.

LTUS

US5457152032

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 10:06:01 2024-04-25 am EDT			5-day change	1st Jan Change
0.005 ^USD	-.--%		-28.57%	+16.28%

2023	Amarin, Lotus Pharmaceuticals Agree to Exclusive Vazkepa Distribution Deal in 10 Asian Countries	MT
2021	Thai oil firm PTT expands pharma business with $475 million Alvogen deal	RE

Lotus Pharmaceuticals, Inc. has Changed its Ticker to LTUS.E from LTUS

April 19, 2012 at 12:00 am EDT

Effective April 19, 2012, Lotus Pharmaceuticals, Inc. changed its OTCBB stock ticker symbol to LTUS.E from LTUS.

Latest news about Lotus Pharmaceuticals, Inc.

Amarin, Lotus Pharmaceuticals Agree to Exclusive Vazkepa Distribution Deal in 10 Asian Countries	23-07-31	MT
Thai oil firm PTT expands pharma business with $475 million Alvogen deal	21-11-26	RE
Lotus Pharmaceuticals : Temasek-backed Vertex expects at least $400 million in new S.E.Asia/India fund	21-09-28	RE
Lotus Pharmaceuticals, Inc. has Changed its Ticker to LTUS from LTUSE	12-05-16	CI
Lotus Pharmaceuticals, Inc. has Changed its Ticker to LTUS.E from LTUS	12-04-19	CI

Chart Lotus Pharmaceuticals, Inc.

Duration

Period

More charts

Lotus Pharmaceuticals, Inc. (Lotus) develops, manufactures, and sells pharmaceuticals in the China. The Company produces crude medicine and drugs in forms of tablets, capsules, granules, eye-drops, and freeze-dried powder injection. Its drug development is focused on the treatment of cerebro-cardiovascular disease, asthma, and diabetes. It operates, controls and owns the pharmaceutical businesses in China of Beijing Liang Fang Pharmaceutical Co., Ltd. (Liang Fang) and Beijing En Zhe Jia Shi Pharmaceutical Co., Ltd. (En Zhe Jia), collectively Lotus East. Lotus East is engaged in the production, trade and retailing of pharmaceuticals, focusing on the development of medicines and investing in strategic growth to address various medical needs. Lotus East owns and operates 10 drug stores throughout Beijing, China that sell Western and traditional Chinese medications, and generate revenues from the leasing of retail space to third party vendors in its retail stores.

Sector

Pharmaceuticals

More about the company

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
LOTUS PHARMACEUTICALS, INC.	+16.28%	14.72M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+19.27%	43.18B
OTSUKA HOLDINGS CO., LTD.	+24.05%	23.23B
SANDOZ GROUP AG	+15.11%	14.6B
ZYDUS LIFESCIENCES LIMITED	+38.36%	11.5B
ONO PHARMACEUTICAL CO., LTD.	-7.63%	6.79B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+10.21%	5.31B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	-2.27%	4.81B

Generic Pharmaceuticals